Find all School-related info fast with the new School-Specific MBA Forum

It is currently 20 Oct 2014, 10:24

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Events & Promotions

Events & Promotions in June
Open Detailed Calendar

Lsat 28 1.25

  Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:
Director
Director
User avatar
Joined: 25 Oct 2008
Posts: 609
Location: Kolkata,India
Followers: 9

Kudos [?]: 192 [0], given: 100

Lsat 28 1.25 [#permalink] New post 03 Sep 2009, 01:26
00:00
A
B
C
D
E

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 100% (00:00) wrong based on 1 sessions
I am confused between C and D..what do you guys think?
Attachments

lsatPreptest28 1.25.pdf [113.43 KiB]
Downloaded 147 times

To download please login or register as a user


_________________

countdown-beginshas-ended-85483-40.html#p649902

Manager
Manager
avatar
Joined: 15 Mar 2008
Posts: 51
Followers: 1

Kudos [?]: 13 [0], given: 0

Re: Lsat 28 1.25 [#permalink] New post 03 Sep 2009, 04:23
Its D for me.
The study is about "efficacy" or effectiveness of the drug.
The 1st speaker is merely saying that the effects of the drug on the group will be different from the effects of the placebo on the other group. He is not necessarily saying that the drug will have its INTENDED effects (therapeutic) on the group. Infact, that is what the study is done for! To find out the effect of a drug on a patient in comparison to "no treatment (placebo group). If the 1st speaker were to imply that, then he would not be saying that its not possible to do the study. Infact, the study would have been successfully concluded!!
What the 1st speaker is implying is that other unintended effects of the drug such as, side-effects of the drug would distinguish the treatment group from the placebo group even before the conclusion of the study. Therefore, it would no longer remain a double-blind study.
The 2nd speaker is misinterpreting the 1st speaker's statement as just that. He is thinking that the 1st speaker has already assumed that the drug is going to treat the group's symptoms and therefore, this group will obviously look different from the placebo group. Well that's what we want at the end of the study to say that the drug is efficacious or effective in treating the illness, but that is not what the 1st speaker is saying.
Director
Director
User avatar
Joined: 25 Oct 2008
Posts: 609
Location: Kolkata,India
Followers: 9

Kudos [?]: 192 [0], given: 100

Re: Lsat 28 1.25 [#permalink] New post 03 Sep 2009, 13:14
Wow u completly nailed this one!Thanks for the gr8 explanation..!
_________________

countdown-beginshas-ended-85483-40.html#p649902

Re: Lsat 28 1.25   [#permalink] 03 Sep 2009, 13:14
    Similar topics Author Replies Last post
Similar
Topics:
3 Lsat 28 1.20 tejal777 5 03 Sep 2009, 01:00
Experts publish their posts in the topic Lsat 28 1.17 tejal777 12 03 Sep 2009, 00:52
Lsat 28 1.16 tejal777 4 03 Sep 2009, 00:45
LSAT PREP 28 #3 tejal777 3 02 Sep 2009, 16:01
LSAT 28 CR(3) tejal777 5 02 Sep 2009, 03:39
Display posts from previous: Sort by

Lsat 28 1.25

  Question banks Downloads My Bookmarks Reviews Important topics  


GMAT Club MBA Forum Home| About| Privacy Policy| Terms and Conditions| GMAT Club Rules| Contact| Sitemap

Powered by phpBB © phpBB Group and phpBB SEO

Kindly note that the GMAT® test is a registered trademark of the Graduate Management Admission Council®, and this site has neither been reviewed nor endorsed by GMAC®.